
PhD student Asmer Aliyeva
Photo Credit: Courtesy of University at Albany
Asmer Aliyeva, a fourth-year PhD candidate in the biology department at the College of Arts and Sciences, is working to reveal the molecular mechanisms behind neurodegenerative diseases. In collaboration with her colleagues in the Berglund Lab, Aliyeva aim is to identify possible therapeutic targets against this class of disease, with a focus on spinocerebellar ataxias (SCAs).
Spinocerebellar ataxias are a group of progressive neurodegenerative diseases that affect coordination and balance, for which there is currently no cure. Aliyeva’s research looks at transcriptomic changes in patient-derived cell lines that could holds clues for common disease mechanisms associated with different types of SCAs.
Recent findings suggest that dysregulation of alternative splicing plays a key role in disease progression, which could lead to new biomarkers and therapeutic discoveries. Aliyeva recently led a study on this topic, coauthored with members of the Berglund Lab at the RNA Institute, published in the journal Human Molecular Genetics.
Aliyeva's research also examines how defects in alternative splicing contribute to the disease and whether these changes can be used as potential biomarkers for monitoring disease onset and progression. This work is a crucial first step in providing a better understanding of potential pathways for future treatments of these diseases.




.jpg)
_MoreDetail-v3_x2_1720x1144.jpg)
_1.jpg)
.jpg)
.jpg)
_MoreDetail-v3_x2_2280x1520.jpg)
_1.jpg)
_MoreDetail-v3_x2_2072x1476.jpg)

